sk&f 104856 has been researched along with epristeride in 1 studies
| Studies (sk&f 104856) | Trials (sk&f 104856) | Recent Studies (post-2010) (sk&f 104856) | Studies (epristeride) | Trials (epristeride) | Recent Studies (post-2010) (epristeride) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 47 | 4 | 4 |
| Protein | Taxonomy | sk&f 104856 (IC50) | epristeride (IC50) |
|---|---|---|---|
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Homo sapiens (human) | 3.4 | |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Rattus norvegicus (Norway rat) | 0.0475 | |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Homo sapiens (human) | 0.0053 | |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Rattus norvegicus (Norway rat) | 0.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
1 review(s) available for sk&f 104856 and epristeride
| Article | Year |
|---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |